Earlier this month, study results showed that molnupiravir, Merck’s investigational antiviral pill, cut hospitalization rates ...

In February, the HHS unexpectedly delivered notice that the South San Francisco-based company was to stop all work on the ...

With the company’s Q1 2025 results on Tuesday, Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to ...

The FDA stressed the treatment should complement rather than replace vaccines, which remain the frontline tool against the coronavirus. But pills that are available at pharmacies should be much ...

The state rushed to stockpile pills after President Donald Trump promoted the drug as a treatment for COVID-19. But soon state leaders were asking for a refund.

WEHI scientists discovered a drug that blocks long COVID in mice and may improve acute treatment options beyond current antivirals like Paxlovid. WEHI researchers have developed a drug compound that ...

HHS Secretary Robert F. Kennedy Jr. is mulling removing the Covid-19 vaccine from the recommended childhood vaccine schedule.

This trend has been highlighted by Palaniappan Manickam, a gastroenterologist and health educator, who remarked on social ...

He has written about Covid-19 vaccines, advances in cancer treatments, drug shortages and the use of mobile devices in healthcare. The agency’s decision to make the company’s Spikevax shot the ...